2012
DOI: 10.4103/0976-7800.104476
|View full text |Cite
|
Sign up to set email alerts
|

Vaginal vault carcinoma as second primary in a treated case of ovarian cancer

Abstract: With the advances in the treatment of cancer, the chances of survival have increased today. The five-year relative survival rate is about 66%. With the increasing survival rate, it is important to identify the late effects of cancer and its therapy. One of the most serious events experienced by cancer survivors is the diagnosis of a new cancer. Case: A 32-year-old unmarried female diagnosed as ovarian cancer in the year 2010. She was treated with three cycles of chemotherapy followed by surgery. Histopathology… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Most of them are secondary to primary in cervix or vagina; some of them secondary to carcinoma ovary/ breast and only only paper reported first-time presentation in the vault as primary. 5 , 6 …”
Section: Discussionmentioning
confidence: 99%
“…Most of them are secondary to primary in cervix or vagina; some of them secondary to carcinoma ovary/ breast and only only paper reported first-time presentation in the vault as primary. 5 , 6 …”
Section: Discussionmentioning
confidence: 99%
“…"History of cervical intraepithelial neoplasia (CIN) is extremely variable and unpredictable when left untreated, CIN may revert to normal", either persist or eventually advance to intrusive cervical malignant growth. The investigation of those that will progress or relapse has critical clinical value [13] P16INK4a, a cancer silencer genetic factor, is a "component of the P16INK4a/cyclinD-cdk4/6/Rb pathway" [14] . It can initiate G1 cell cycle capture by repressing the "phosphorylation of pRb by cdk4 and cdk6" [12] Current investigations demonstrates that immunohistochemical stain techniques with "P16INK4a is a promising marker for dysplastic and cancerous cervical epithelia" [15] .…”
Section: Introductionmentioning
confidence: 99%